APEX Trial

Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Overview

The APEX Trial is a trial of the Factor Xa inhibitor betrixaban in the management of medically ill patients.